Literature DB >> 27137188

Effect of CD133 overexpression on the epithelial-to-mesenchymal transition in oral cancer cell lines.

YeonHee Moon1, Donghwi Kim2, HongMoon Sohn2, Wonbong Lim3,4.   

Abstract

Oral squamous cell carcinoma (OSCC) is one of the most common cancers in the world. In OSCC, CD133 promotes tumor invasion and metastasis by inducing the epithelial-to-mesenchymal transition (EMT). A small subset of cancer cells known as cancer stem cells (CSCs) are thought to give rise to differentiated tumor cells and to predict tumor recurrence and metastases, i.e., CSCs may be metastatic precursors. In this study, we show that ectopic overexpression of CD133 in OSCC cell lines KB, YD9, and YD10B cells significantly promotes the EMT and acquisition of stemness properties. CSC properties were analyzed by colony-formation assay and measurement of OCT4, SOX2, and NANOG expression, and the EMT was monitored by cell migration, a cell invasion assay, and analysis of E-cadherin, N-cadherin, and vimentin expression. CD133 overexpression led to formation of irregular spheroid colonies consistent with a stem cell phenotype and increased the expression of OCT4, SOX2, NANOG, N-cadherin, and vimentin. Taken together, these findings show that elevated levels of CD133 lead to OSCC invasiveness and metastasis, associated with the upregulation of EMT and stemness markers.

Entities:  

Keywords:  CD133; Cancer stem cell; Carcinogenesis; Epithelial-to-mesenchymal transition

Mesh:

Substances:

Year:  2016        PMID: 27137188     DOI: 10.1007/s10585-016-9793-y

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  34 in total

1.  Recent advances in head and neck cancer.

Authors:  Robert I Haddad; Dong M Shin
Journal:  N Engl J Med       Date:  2008-09-11       Impact factor: 91.245

2.  The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions.

Authors:  D Corbeil; K Röper; A Hellwig; M Tavian; S Miraglia; S M Watt; P J Simmons; B Peault; D W Buck; W B Huttner
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

Review 3.  Nodal metastases and prognosis in carcinoma of the oral cavity.

Authors:  J F DiTroia
Journal:  Otolaryngol Clin North Am       Date:  1972-06       Impact factor: 3.346

4.  Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.

Authors:  Lilly Y W Bourguignon; Gabriel Wong; Christine Earle; Liqun Chen
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

Review 5.  Apoptosis in normal and cancer stem cells.

Authors:  Gioacchin Iannolo; Concetta Conticello; Lorenzo Memeo; Ruggero De Maria
Journal:  Crit Rev Oncol Hematol       Date:  2007-11-26       Impact factor: 6.312

Review 6.  CD133: molecule of the moment.

Authors:  D Mizrak; M Brittan; M R Alison
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

7.  Cancerous stem cells can arise from pediatric brain tumors.

Authors:  Houman D Hemmati; Ichiro Nakano; Jorge A Lazareff; Michael Masterman-Smith; Daniel H Geschwind; Marianne Bronner-Fraser; Harley I Kornblum
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-26       Impact factor: 11.205

8.  Selective apoptotic effect of Zelkova serrata twig extract on mouth epidermoid carcinoma through p53 activation.

Authors:  Hoe-Jin Kang; Young-Joo Jang
Journal:  Int J Oral Sci       Date:  2012-04-13       Impact factor: 6.344

9.  Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma.

Authors:  Chao Chen; Yan Wei; Michael Hummel; Thomas K Hoffmann; Manfred Gross; Andreas M Kaufmann; Andreas E Albers
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

10.  G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma.

Authors:  Shuli Liu; Dongxia Ye; Wenzheng Guo; Wenwen Yu; Yue He; Jingzhou Hu; Yanan Wang; Ling Zhang; Yueling Liao; Hongyong Song; Shuangshuang Zhong; Dongliang Xu; Huijing Yin; Beibei Sun; Xiaofei Wang; Jingyi Liu; Yadi Wu; Binhua P Zhou; Zhiyuan Zhang; Jiong Deng
Journal:  Oncotarget       Date:  2015-03-30
View more
  6 in total

1.  Chemoresistance to 5-FU inhibited by 635 nm LED irradiation in CD133+ KB cell line.

Authors:  Donghwi Kim; Mineon Park; Hyunwoong Jang; Hoon Hyun; Wonbong Lim
Journal:  Lasers Med Sci       Date:  2017-09-27       Impact factor: 3.161

2.  CD133 Expression Predicts Relapse in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemotherapy.

Authors:  Haruka Oi; Takashi Okuyama; Shunya Miyazaki; Yuko Ono; Masatoshi Oya
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

3.  A GLIS3-CD133-WNT-signaling axis regulates the self-renewal of adult murine pancreatic progenitor-like cells in colonies and organoids.

Authors:  Jacob R Tremblay; Kassandra Lopez; Hsun Teresa Ku
Journal:  J Biol Chem       Date:  2019-09-18       Impact factor: 5.157

Review 4.  Literature review of cancer stem cells in oral lichen planus: a premalignant lesion.

Authors:  Mahdieh-Sadat Moosavi; Fatemeh Tavakol
Journal:  Stem Cell Investig       Date:  2021-12-30

Review 5.  Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.

Authors:  Dhiraj Kumar; Mahadeo Gorain; Gautam Kundu; Gopal C Kundu
Journal:  Mol Cancer       Date:  2017-01-30       Impact factor: 27.401

6.  Effect of CD133 overexpression on bone metastasis in prostate cancer cell line LNCaP.

Authors:  Hong Moon Sohn; Bora Kim; Mineon Park; Young Jong Ko; Yeon Hee Moon; Jae Myung Sun; Byung-Cheol Jeong; Young Wook Kim; Wonbong Lim
Journal:  Oncol Lett       Date:  2019-06-06       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.